Today's hot alert includes : Micromet, Inc. (Nasdaq: MITI)
Micromet to Present at The 8th Annual BIO Investor Forum Conference on October 29, 2009
BETHESDA, Md., Oct. 21 -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that its Senior Vice President and Chief Financial Officer, Barclay Phillips, will present at The 8th Annual BIO Investor Forum on October 29, 2009 in San Francisco. A simultaneous webcast of the event will be available on the company's website at www.micromet-inc.com.
Monsterstox.com offers daily newsletter on potentially huge movers in the market. These include stocks with momentum and abnormal volume. We also profile undervalued stocks, penny stocks, stocks with positive technical indicators and much more. Our team of experienced Traders search the market for stocks that are overlooked by the crowd.
We encourage investors to join to our FREE newsletter by visiting: http://www.Monsterstox.com
ABOUT MONSTERSTOX.COM
Monsterstox.com is a leading stock website that provides FREE newsletters on stocks that are potential huge movers. Monsterstox.com also tracks micro cap stocks that could be undervalued by the market. Monsterstox.com strives to provide an edge to Traders and Investors with its FREE newsletter service.
Monsterstox.com is an independent electronic publication that provides information on selected publicly traded companies. Monsterstox.com is not a registered investment advisor or broker-dealer. Monsterstox.com affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.
CONTACT: Monsterstox.com e-mail: info@monsterstox.com
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index